Ignite Creation Date:
2024-05-06 @ 1:26 AM
Last Modification Date:
2024-10-26 @ 11:04 AM
Study NCT ID:
NCT01806077
Status:
COMPLETED
Last Update Posted:
2016-04-21
First Post:
2013-03-01
Brief Title:
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Sponsor:
Tufts Medical Center
Organization:
Tufts Medical Center
Study Overview
Official Title:
Demonstration of the Safety Tolerability Pharmacokinetics and Pharmacodynamic Antiplatelet Effect of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a Phase I intravenous single-dose escalation study to evaluate the safety tolerability pharmacokinetics and pharmacodynamics of PZ-128 pepducin inhibitor of PAR1 in subjects with vascular disease or who have 2 or more coronary artery disease CAD risk factors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P50HL110789 | NIH | None | httpsreporternihgovquickSearchP50HL110789 |